Last Updated: September 28 2022

Calcium-D-Glucarate is a β-glucuronidase inhibitor that promotes the excretion of any molecule in a specific detoxification pathway. It has shown efficacy at very high (impractical) oral doses in reducing cancer induced by these compounds, but may also reduce all steroid hormones as well.

Calcium-D-Glucarate is most often used for


For the most part, Calcium-D-Glucarate is just known to be a β-glucuronidase inhibitor via its metabolite D-glucaro-1,4-lactone. The process of 'glucuronidation' is a detoxification process where a group (known as a glucuronide) is attached to a hydrophobic molecule to make it more water soluble, and then the kidneys can better facilitate its removal from the body. This process is positively mediated by the glucuronosyltransferase enzyme, and negatively mediated by the β-glucuronidase enzyme; as such, inhibiting the negative regulator (the enzyme that removes the glucuronide) indirectly increases the activity of this pathway.

It is touted to be an anticancer agent, which is due to a series of past research done in rats and mice exposed to the DMBA toxin which is known to be glucuronidated. There are definitely anticancer effects in these models, and it appears to extend to other toxins that are glucuronidated.

However, a problem occurs when humans take this as an oral supplement. Although it appears to be safe even at high doses, very high doses are required for its effects (100mg/kg minimum, near maximal effects at 200mg/kg) and this would even only theoretically assure some protection against toxins that are glucuronidated. If a toxin can't be glucuronidated and requires another detoxification pathway, it will serve no benefit.

Organ cancer production which just occurs spontaneously because of oxidative stress to DNA is also not likely to be protected against, as increasing glucuronidation does not per se decrease oxidative stress in the body (it might just reduce the oxidative effects of toxins).

Furthermore, all steroid hormones in the body (testosterone, estrogen, DHEA, etc.) are also glucuronidated. If using an oral dose that reduces the toxin, these hormones will also all be reduced for a short time.

Using calcium-D-glucarate as a daily preventative supplement does not appear to be a prudent idea, due to its lack of reliability even in theory and high doses used. However, a single acute dose of this supplement prior to known exposure to toxins that are glucuronidated (such as both benzopyrene and polyaromatic hydrocarbon compounds produced in the cooking of meat products) might be more prudent and potentially useful.

What else is Calcium-D-Glucarate known as?
Note that Calcium-D-Glucarate is also known as:
  • Calcium Glucarate
  • Saccharic acid
  • Calcium-D-Saccharate
  • Glucaric acid
Calcium-D-Glucarate should not be confused with:
  • Calcium (individual ion)
  • Glucuronolactone (sounds similar to the metabolite D-glucaro-1
  • 4-lactone)
  • Glutamine (not glucaric acid)
  • Saccharin (not saccharic acid)
Dosage information

The recommended dosage range (from supplement providers) is in the range of 1,500-3,000mg daily. Based on animal research, this does appear to be quite low and a minimum of 200mg/kg for humans may be needed to replicate the research (also based further on animal research, a 200mg/kg human dose is around the point where dose-dependent returns attenuate greatly and is the 'ideal' dose, below this dosage is a linear drop in efficacy with 100mg/kg being half as effective)

At this moment in time, it may be prudent to only used calcium-D-glucarate at a 100-200mg/kg dosage prior to known exposure to toxins that are glucuronidated; it may not be financially prudent to take it as a daily preventative supplement.

Join our supplement information course

Don't miss out on the latest research

1.^[No authors listedCalcium-D-glucarateAltern Med Rev.(2002 Aug)
3.^Dwivedi C, Heck WJ, Downie AA, Larroya S, Webb TEEffect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruitsBiochem Med Metab Biol.(1990 Apr)
4.^Walaszek Z, Szemraj J, Narog M, Adams AK, Kilgore J, Sherman U, Hanausek MMetabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer preventionCancer Detect Prev.(1997)
5.^Walaszek Z, Hanausek M, Narog M, Raich PC, Slaga TJMechanisms of lung cancer chemoprevention by D-glucarateChest.(2004 May)
6.^Walaszek Z, Hanausek-Walaszek M, Minton JP, Webb TEDietary glucarate as anti-promoter of 7,12-dimethylbenz{a}anthracene-induced mammary tumorigenesisCarcinogenesis.(1986 Sep)
8.^Heerdt AS, Young CW, Borgen PICalcium glucarate as a chemopreventive agent in breast cancerIsr J Med Sci.(1995 Feb-Mar)
13.^Nemoto N, Hirakawa T, Takayama SGlucuronidation of benzo{a}pyrene in hamster embryo cellsChem Biol Interact.(1978 Jul)
14.^Jørgensen A, Glessing AM, Rasmussen LJ, Andersen OBiotransformation of the polycyclic aromatic hydrocarbon pyrene in the marine polychaete Nereis virensEnviron Toxicol Chem.(2005 Nov)
17.^Poon R, Villeneuve DC, Chu I, Kinach RHPLC determination of D-glucaric acid in human urineJ Anal Toxicol.(1993 May-Jun)
18.^Pacifici GM, Gucci A, Giuliani LTestosterone sulphation and glucuronidation in the human liver: interindividual variabilityEur J Drug Metab Pharmacokinet.(1997 Jul-Sep)
19.^Ekström L, Cevenini L, Michelini E, Schulze J, Thörngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane ATestosterone challenge and androgen receptor activity in relation to UGT2B17 genotypesEur J Clin Invest.(2013 Mar)
21.^Walaszek Z, Hanausek M, Sherman U, Adams AKAntiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary glandCancer Lett.(1990 Jan)
23.^Kowalczyk MC, Spears E, Narog M, Zoltaszek R, Kowalczyk P, Hanausek M, Yoshimi N, Slaga TJ, Walaszek ZModulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursorsOncol Rep.(2011 Sep)
25.^Lajolo C, Sgambato A, Maiorano E, Lucchese A, Capodiferro S, Favia G, Giuliani MCalcium glucarate inhibits DMBA-induced oral carcinogenesis in the hamster: histomorphometric evaluationAnticancer Res.(2010 Mar)
26.^Yoshimi N, Walaszek Z, Mori H, Hanausek M, Szemraj J, Slaga TJInhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarateInt J Oncol.(2000 Jan)
28.^Takada H, Hirooka T, Hiramatsu Y, Yamamoto MEffect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in ratsCancer Res.(1982 Jan)
29.^Olas B, Saluk-Juszczak J, Wachowicz BD-glucaro 1,4-lactone and resveratrol as antioxidants in blood plateletsCell Biol Toxicol.(2008 Apr)
30.^Kowalczyk MC, Kowalczyk P, Tolstykh O, Hanausek M, Walaszek Z, Slaga TJSynergistic effects of combined phytochemicals and skin cancer prevention in SENCAR miceCancer Prev Res (Phila).(2010 Feb)
33.^Walaszek Z, Hanausek-Walaszek M, Webb TEDietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesisCancer Lett.(1986 Oct)